Regarding the determination of autoantibodies in patients with T1D, it has been reported that the prevalence of anti-GAD oscillates between 60 and 85%, while the determination of anti-IA2 varies between 70 and 90% of patients [37]. Here, PTPRN is linked to type 1 diabetes mellitus.